Page last updated: 2024-08-25

atovaquone and Chorioretinitis

atovaquone has been researched along with Chorioretinitis in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (44.44)	18.2507
2000's	1 (11.11)	29.6817
2010's	4 (44.44)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chorlton, SD	1
Fekrat, S; Proia, AD; Rao, V; Schneider, E	1
Godehardt, E; Joussen, AM; Maier, AK; Severing, K; Stammen, J; Winterhalter, S	1
Freund, KB; Holland, GN; Kreiger, AE; Nguyen, QD; Vance, SK; Wenick, AS	1
Baatz, H; Gümbel, H; Hattenbach, LO; Mirshahi, A; Puchta, J	1
Althaus, C; Armbrecht, C; Jablonowski, H; Schimkat, M; Sundmacher, R	1
Althaus, C; Hudde, T; Schimkat, M; Sundmacher, R	1
Gormley, PD; Lightman, S; Minnasian, D; Pavesio, CE	1
Jaffe, GJ; Pearson, PA; Piracha, AR; Sen, HA	1

Trials

2 trial(s) available for atovaquone and Chorioretinitis

Article	Year
Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis? Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2010, Volume: 248, Issue:8 Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Atovaquone; Chorioretinitis; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Secondary Prevention; Toxoplasmosis, Ocular; Visual Acuity; Young Adult	2010
Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients. Ophthalmology, 1999, Volume: 106, Issue:1 Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Atovaquone; Chorioretinitis; Drug Evaluation; Female; Follow-Up Studies; Fundus Oculi; Humans; Immunocompetence; Middle Aged; Naphthoquinones; Prospective Studies; Safety; Toxoplasmosis, Ocular; Treatment Outcome; Visual Acuity	1999

Article

Year

Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis?

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2010, Volume: 248, Issue:8

Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Atovaquone; Chorioretinitis; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Secondary Prevention; Toxoplasmosis, Ocular; Visual Acuity; Young Adult

2010

Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients.

Ophthalmology, 1999, Volume: 106, Issue:1

Topics: Adolescent; Adult; Aged; Antiprotozoal Agents; Atovaquone; Chorioretinitis; Drug Evaluation; Female; Follow-Up Studies; Fundus Oculi; Humans; Immunocompetence; Middle Aged; Naphthoquinones; Prospective Studies; Safety; Toxoplasmosis, Ocular; Treatment Outcome; Visual Acuity

1999

Other Studies

7 other study(ies) available for atovaquone and Chorioretinitis

Article	Year
Adjunctive bradyzoite-directed therapy for reducing complications of congenital toxoplasmosis. Medical hypotheses, 2019, Volume: 133 Topics: Animals; Antiprotozoal Agents; Atovaquone; Brain; Chorioretinitis; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eye; Humans; Infant; Infant, Newborn; Mice; Models, Biological; Recurrence; Spiramycin; Toxoplasma; Toxoplasmosis, Animal; Toxoplasmosis, Cerebral; Toxoplasmosis, Congenital; Toxoplasmosis, Ocular	2019
Development of bilateral acquired toxoplasmic retinochoroiditis during erlotinib therapy. JAMA ophthalmology, 2014, Volume: 132, Issue:9 Topics: Adenocarcinoma; Anti-Infective Agents; Atovaquone; Chorioretinitis; ErbB Receptors; Erlotinib Hydrochloride; Female; Food Parasitology; Humans; Lung Neoplasms; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Toxoplasma; Toxoplasmosis, Ocular	2014
Diagnostic and therapeutic challenges. Retina (Philadelphia, Pa.), 2011, Volume: 31, Issue:6 Topics: Adult; Anti-Infective Agents; Atovaquone; Chorioretinitis; Diagnosis, Differential; Eye Diseases; Female; Fluorescein Angiography; Humans; Recurrence; Tomography, Optical Coherence; Toxoplasmosis, Ocular; Visual Acuity; Vitreous Body	2011
Reactivation of toxoplasma retinochoroiditis under atovaquone therapy in an immunocompetent patient. Ocular immunology and inflammation, 2006, Volume: 14, Issue:3 Topics: Adult; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Atovaquone; Chorioretinitis; Drug Resistance, Microbial; Female; Humans; Immunocompetence; Naphthoquinones; Oxidoreductases; Recurrence; Toxoplasma; Toxoplasmosis, Ocular; Visual Acuity	2006
[Treatment of toxoplasmosis retinochoroiditis with atovaquone in an AIDS patient]. Klinische Monatsblatter fur Augenheilkunde, 1995, Volume: 206, Issue:3 Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Atovaquone; Chorioretinitis; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluorescein Angiography; Follow-Up Studies; Humans; Male; Middle Aged; Naphthoquinones; Toxoplasmosis, Ocular	1995
[Treatment of toxoplasmosis retinochoroiditis with atovaquone in an immunocompetent patient]. Klinische Monatsblatter fur Augenheilkunde, 1996, Volume: 209, Issue:4 Topics: Adult; Animals; Antiprotozoal Agents; Atovaquone; Chorioretinitis; Female; Follow-Up Studies; Humans; Male; Naphthoquinones; Recurrence; Toxoplasma; Toxoplasmosis, Ocular	1996
Effects of drug therapy on Toxoplasma cysts in an animal model of acute and chronic disease. Investigative ophthalmology & visual science, 1998, Volume: 39, Issue:7 Topics: Acute Disease; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Atovaquone; Brain; Chorioretinitis; Chronic Disease; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Female; Mesocricetus; Naphthoquinones; Retina; Toxoplasma; Toxoplasmosis, Cerebral; Toxoplasmosis, Ocular	1998